|
|
Blood, 1 December 2004, Vol. 104, No. 12, pp. 3454-3462.
Prepublished online as a Blood First Edition Paper on August 12, 2004; DOI 10.1182/blood-2004-04-1678.
Previous Article | Table of Contents | Next Article 
REVIEW ARTICLES
Mechanisms of WASp-mediated hematologic and immunologic disease
Siobhan Burns,
Giles O. Cory,
William Vainchenker, and
Adrian J. Thrasher
From the Molecular Immunology Unit, Institute of Child Health, University College London, United Kingdom; Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom; the Biochemistry Department, University of Bristol, Bristol, United Kingdom; and the Institut National de la santé etdela recherche médicale (INSERM) Unit 362 and Institut Gustave Roussy, INSERM U 362, Hematopoièse et cellules souches, Villejuif, Cedex, France.
The Wiskott-Aldrich syndrome protein (WASp) is a key regulator of actin polymerization in hematopoietic cells. The dynamic nature of cytoskeletal changes during a variety of cellular processes demands complex mechanisms for coordinated integration of input signals, precise localization within the cell, and regulated activation of the Arp2/3 complex. Mutations in the Wiskott-Aldrich syndrome gene either inhibit or dysregulate normal WASp function, resulting in clinical diseases with complex and disparate phenotypes. This review highlights recent advances that have enhanced our understanding of the mechanisms by which these molecular defects cause hematologic and immunologic disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Pulecio, E. Tagliani, A. Scholer, F. Prete, L. Fetler, O. R. Burrone, and F. Benvenuti
Expression of Wiskott-Aldrich Syndrome Protein in Dendritic Cells Regulates Synapse Formation and Activation of Naive CD8+ T Cells
J. Immunol.,
July 15, 2008;
181(2):
1135 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsuboi and J. Meerloo
Wiskott-Aldrich Syndrome Protein Is a Key Regulator of the Phagocytic Cup Formation in Macrophages
J. Biol. Chem.,
November 23, 2007;
282(47):
34194 - 34203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Moulding, M. P. Blundell, D. G. Spiller, M. R.H. White, G. O. Cory, Y. Calle, H. Kempski, J. Sinclair, P. J. Ancliff, C. Kinnon, et al.
Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia
J. Exp. Med.,
September 3, 2007;
204(9):
2213 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-S. Liu, X.-H. Li, Y. Wang, R.-Z. Shu, L. Wang, S.-Y. Lu, H. Kong, Y.-E Jin, L.-J. Zhang, J. Fei, et al.
Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver
Blood,
August 1, 2007;
110(3):
870 - 876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, N. Clough, X. Sun, W. Yu, B. L. Abbott, C. J. Hogan, and Z. Dai
Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway
J. Cell Sci.,
April 15, 2007;
120(8):
1436 - 1446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsuboi
Requirement for a Complex of Wiskott-Aldrich Syndrome Protein (WASP) with WASP Interacting Protein in Podosome Formation in Macrophages
J. Immunol.,
March 1, 2007;
178(5):
2987 - 2995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Konno, M. Kirby, S. A. Anderson, P. L. Schwartzberg, and F. Candotti
The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP)
Int. Immunol.,
February 1, 2007;
19(2):
185 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Trifari, G. Sitia, A. Aiuti, S. Scaramuzza, F. Marangoni, L. G. Guidotti, S. Martino, P. Saracco, L. D. Notarangelo, M.-G. Roncarolo, et al.
Defective Th1 Cytokine Gene Transcription in CD4+ and CD8+ T Cells from Wiskott-Aldrich Syndrome Patients
J. Immunol.,
November 15, 2006;
177(10):
7451 - 7461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Binder, M. H. Albert, M. Kabus, M. Bertone, A. Meindl, and B. H. Belohradsky
The Genotype of the Original Wiskott Phenotype
N. Engl. J. Med.,
October 26, 2006;
355(17):
1790 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Ancliff, M. P. Blundell, G. O. Cory, Y. Calle, A. Worth, H. Kempski, S. Burns, G. E. Jones, J. Sinclair, C. Kinnon, et al.
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia
Blood,
October 1, 2006;
108(7):
2182 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sabri, A. Foudi, S. Boukour, B. Franc, S. Charrier, M. Jandrot-Perrus, R. W. Farndale, A. Jalil, M. P. Blundell, E. M. Cramer, et al.
Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment
Blood,
July 1, 2006;
108(1):
134 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Lutskiy, D. S. Beardsley, F. S. Rosen, and E. Remold-O'Donnell
Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome
Blood,
October 15, 2005;
106(8):
2815 - 2817.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|